Wanhua Cuts Investment by 35 Percent for 2025 Shifts Focus to High-Quality Growth
On May 8, Wanhua Chemical unveiled its 2024 shareholder meeting materials, revealing a 35% reduction in total planned investment for 2025, down to ¥29.43 billion. This shift signals a move away from aggressive expansion and toward refined, high-efficiency development amid rising market challenges.
In 2024, Wanhua executed ¥42.83 billion in investments, achieving a 94% completion rate against its ¥45.4 billion plan. Among these, ¥40.15 billion was allocated to project construction, spanning polyurethanes, petrochemicals, fine chemicals, new materials, and infrastructure. Additionally, ¥2.68 billion was used for equity investments in strategic sectors.
For 2025, Wanhua plans to spend ¥25.24 billion on major projects, emphasizing MDI capacity expansion, a 1-million-ton ethylene revamp, and second-phase ethylene development. Investment in fine chemicals like vanillin, nutritional products, and green additives is set at ¥4.64 billion, while emerging material sectors including lithium iron phosphate and PVDF will receive ¥2.16 billion.
Equity investment will climb to ¥4.19 billion, focused on battery materials, new materials, and global expansion, leveraging the company’s integrated industrial park model for collaborative synergies across upstream and downstream players.
In 2024, Wanhua made strides in synthetic biology and electrochemical R&D, building its next growth curve with acquisitions across the battery materials chain. Key milestones include the start-up of the Penglai park and steady progress on its large-scale ethylene Phase II project.
Despite headwinds in petrochemicals and global oversupply, Wanhua’s marketing approach—focusing on collaboration, ecosystem-building, and premium application development—has enabled stronger margins and reinforced its leadership in high-end markets. Its fine chemicals and advanced materials segments navigated soft demand by emphasizing cost control, product differentiation, and international reach, with multiple new production lines achieving stable output.
With 2025 designated as its “Year of Transformation,” Wanhua is pursuing deep organizational, mindset, budget, and incentive reforms. The aim is to pivot from external volume-driven growth to internal, performance-based value creation, linking employee incentives directly to business results and building a culture of entrepreneurship and accountability. Wanhua is retooling for resilience, ready to lead even in a turbulent market.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Wanhua Chemical Expands TPU Production by 200,000 Tons with RMB 287 Million Investment
-
Aster Opens Singapore’s Storage and Marine Network to Third Parties
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
Two Major Dye Giants Hike Prices Consecutively: Longsheng Raises Prices by Up to RMB 10,000/Ton, Yabang Increases Some Products by RMB 60,000/Ton
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Azelis Strengthens Partnership with SI Group, Becoming Its New Distributor of Plastic Additives
-
BASF’s Zhanjiang Integrated Site Commissions New Neopentyl Glycol (NPG) Unit
-
BASF and IFF Collaborate to Accelerate Innovation in Enzymes and Polymers
-
When Light Falls on Metal: The Industrial Romance of Xiaomi × BASF
Recommend Reading
-
Haldia Petrochemicals Pipeline Fire in India Adds Uncertainty to Asia's Naphtha Market
-
Sinochem International Acquires Nantong Xingchen for 2.11 Billion Yuan, Rike Chemical Plans Genyuan New Materials Acquisition – The Changing Landscape of Chemical M&A
-
Soybeans Tread Water Amid Trade Whispers and Biofuel Hopes
-
COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
This week, the styrene market in China showed a weak decline (6.22-6.26)
-
Weekly Caustic Soda Price Consolidation Trend (6.22-6.26) in China
-
Sodium Pentothal: Medical Applications and Safety
-
MTBE Market Prices Continue to Decline
-
Crude oil prices fall, retail prices of refined oil products in China continue to decrease